The JV is owned 55 % Mitsubishi Gas Chemical and 45 % by Nippon Kayaku. The manufacturing facility will provide 1000 and 2000 L scale culture vessels for the production of biosimilars from reombinant animal cells or microorganisms.

Mitsubishi Gas Chemical news release, June 8, 2016